Welch Group LLC reduced its stake in Clorox Co. (NYSE:CLX) by 34.1% during the second quarter, according to its most recent filing with the SEC. The fund owned 1,014 shares of the company’s stock after selling 524 shares during the period. Welch Group LLC’s holdings in Clorox were worth $140,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of the company. Invictus RG bought a new stake in Clorox during the first quarter valued at about $110,000. Checchi Capital Advisers LLC increased its stake in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares during the last quarter. Mutual of Omaha Bank Wealth Management increased its stake in Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock valued at $226,000 after buying an additional 300 shares during the last quarter. Paragon Capital Management Ltd bought a new stake in Clorox during the second quarter valued at about $232,000. Finally, Sand Hill Global Advisors LLC increased its stake in Clorox by 12.7% in the first quarter. Sand Hill Global Advisors LLC now owns 2,142 shares of the company’s stock valued at $270,000 after buying an additional 241 shares during the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) traded down 0.69% during midday trading on Monday, hitting $124.32. The company had a trading volume of 705,347 shares. Clorox Co. has a 12-month low of $117.08 and a 12-month high of $140.47. The firm has a market capitalization of $16.10 billion, a P/E ratio of 25.27 and a beta of 0.30. The firm’s 50-day moving average is $127.93 and its 200-day moving average is $130.05.
Clorox (NYSE:CLX) last released its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the company posted $1.44 EPS. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. On average, analysts predict that Clorox Co. will post $5.49 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be paid a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 2.57%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s payout ratio is 64.91%.
Several analysts have issued reports on the company. Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 price objective on the stock in a report on Friday, September 16th. B. Riley restated a “neutral” rating and set a $109.00 price objective on shares of Clorox in a report on Tuesday, August 9th. Citigroup Inc. boosted their price objective on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a report on Monday, August 8th. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective on the stock in a report on Monday, August 8th. Finally, Goldman Sachs Group Inc. restated a “neutral” rating and set a $130.00 price objective on shares of Clorox in a report on Thursday, August 4th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $128.90.
In other Clorox news, COO Dawn C. Willoughby sold 10,617 shares of the stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total value of $1,390,933.17. Following the transaction, the chief operating officer now owns 20,353 shares of the company’s stock, valued at $2,666,446.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Nikolaos A. Vlahos sold 925 shares of the firm’s stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $133.07, for a total value of $123,089.75. The disclosure for this sale can be found here. 0.74% of the stock is owned by company insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.